Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$315.92 - $397.36 $4,106 - $5,165
-13 Reduced 1.52%
844 $268,000
Q3 2022

Oct 26, 2022

SELL
$263.81 - $337.27 $4,484 - $5,733
-17 Reduced 1.95%
857 $226,000
Q2 2022

Jul 27, 2022

SELL
$301.4 - $428.42 $3,616 - $5,141
-12 Reduced 1.35%
874 $274,000
Q3 2021

Nov 04, 2021

SELL
$396.76 - $455.92 $5,554 - $6,382
-14 Reduced 1.56%
886 $366,000
Q2 2021

Jul 28, 2021

SELL
$372.36 - $412.07 $3,723 - $4,120
-10 Reduced 1.1%
900 $357,000
Q1 2021

Apr 26, 2021

SELL
$357.26 - $392.57 $7,859 - $8,636
-22 Reduced 2.36%
910 $350,000
Q4 2020

Feb 04, 2021

SELL
$319.05 - $363.32 $8,295 - $9,446
-26 Reduced 2.71%
932 $339,000
Q4 2017

Sep 25, 2018

BUY
$217.88 - $244.43 $208,729 - $234,163
958
958 $209,000

Others Institutions Holding COO

About COOPER COMPANIES, INC.


  • Ticker COO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 49,346,000
  • Market Cap $4.92B
  • Description
  • The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...
More about COO
Track This Portfolio

Track Portfolio Strategies, Inc. Portfolio

Follow Portfolio Strategies, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Portfolio Strategies, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Portfolio Strategies, Inc. with notifications on news.